ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Aptus Pharma Limited issued a clarification regarding typographical errors in its August 8, 2026, board meeting outcome. The correction specifies the meeting venue and annexure titles.
Aptus Pharma's board approved a ₹51 Crore fund raise via preferential allotment and debt. The move supports business expansion, pending shareholder and regulatory approvals.
Aptus Pharma Ltd has scheduled a Board Meeting on April 27, 2026, to consider and approve audited financial results for the half-year and year ended March 31, 2026. The company also announced the closure of its trading window until 48 hours after the results declaration.